Improvement of pentylenetetrazol-induced learning deficits by valproic acid in the adult zebrafish

European Journal of Pharmacology

Volumn 643, Issue 2-3, 2010, Pages 225-231

  Lee, Yunkyoung ^a   Kim, Dohee ^a   Kim, Yeon Hwa ^a   Lee, Hansol ^a   Lee, Chang Joong ^a  

^a Inha University   (South Korea)

Author keywords

Avoidance learning; Danio rerio; Pentylenetetrazol; Seizure; Valproic acid

Indexed keywords

HEAT SHOCK PROTEIN 70; MESSENGER RNA; PENTETRAZOLE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; INVOLUNTARY MOVEMENT; LEARNING DISORDER; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; ZEBRA FISH;

EID: 77955271774     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.041     Document Type: Article

References (40)

1. Ammon-Treiber S., Grecksch G., Angelidis C., Vezyraki P., Hollt V., Becker A. Pentylenetetrazol-kindling in mice overexpressing heat shock protein 70. Naunyn-Schmiedeberg's Arch. Pharmacol. 2007, 375:115-121.
2. Baraban S.C., Taylor M.R., Castro P.A., Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 2005, 131:759-768.
3. Becker A., Grecksch G., Ruthrich H.L., Pohle W., Marx B., Matthies H. Kindling and its consequences on learning in rats. Behav. Neural Biol. 1992, 57:37-43.
4. Becker A., Grecksch G., Brosz M. Antiepileptic drugs-their effects on kindled seizures and kindling-induced learning impairments. Pharmacol. Biochem. Behav. 1995, 52:453-459.
5. Berghmans S., Hunt J., Roach A., Goldsmith P. Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res. 2007, 75:18-28.
6. Bolanos A.R., Sarkisian M., Yang Y., Hori A., Helmers S.L., Mikati M., Tandon P., Stafstrom C.E., Holmes G.L. Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 1998, 51:41-48.
7. Brandt C., Gastens A.M., Sun M., Hausknecht M., Loscher W. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 2006, 51:789-804.
8. Brown-Croyts L.M., Caton P.W., Radecki D.T., McPherson S.L. Phenobarbital pre-treatment prevents kainic acid-induced impairments in acquisition learning. Life Sci. 2000, 67:643-650.
9. Chen G., Zeng W.Z., Yuan P.X., Huang L.D., Jiang Y.M., Zhao Z.H., Manji H.K. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J. Neurochem. 1999, 72:879-882.
10. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 1995, 36(Suppl 2):46-65.
11. Dodrill C.B. Correlates of generalized tonic-clonic seizures with intellectual, neuropsychological, emotional, and social function in patients with epilepsy. Epilepsia 1986, 27:399-411.
12. Elger C.E., Helmstaedter C., Kurthen M. Chronic epilepsy and cognition. Lancet Neurol. 2004, 3:663-672.
13. Gastens A.M., Brandt C., Bankstahl J.P., Löscher W. Predictors of pharmacoresistant epilepsy: pharmacoresistant rats differ from pharmacoresponsive rats in behavioral and cognitive abnormalities associated with experimentally induced epilepsy. Epilepsia 2008, 49:1759-1776.
14. Gidal B.E., Pitterle M.E., Spencer N.W., Maly M.M. Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy. J. Clin. Pharm. Ther. 1995, 20:215-219.
15. Giovagnoli A.R., Erbetta A., Villani F., Avanzini G. Semantic memory in partial epilepsy: verbal and non-verbal deficits and neuroanatomical relationships. Neuropsychologia 2005, 43:1482-1492.
16. Guo S. Linking genes to brain, behavior and neurological diseases: what can we learn. Genes Brain Behav. 2004, 3:63-74.
17. Gupta Y.K., Malhotra J. Effect of theophylline on diazepam and sodium valproate protection in pentylenetetrazole-kindled seizures in rats. Indian J. Physiol. Pharmacol. 1997, 41:280-284.
18. Halgren E., Stapleton J., Domalski P., Swartz B.E., Delgado-Escueta A.V., Walsh G.O., Mandelkern M., Blahd W., Ropchan J. Memory dysfunction in epilepsy patients as a derangement of normal physiology. Adv. Neurol. 1991, 55:385-410.
19. Jeon G.S., Park S.H., Lee K.J., Lee M.S., Chun B.G., Shin K.H. Valproate prevents MK801-induced changes in brain-derived neurotrophic factor mRNA in the rat brain. Eur. J. Pharmacol. 2006, 545:142-146.
20. Jeong J.Y., Kwon H.B., Ahn J.C., Kang D., Kwon S.H., Park J.A., Kim K.W. Functional and developmental analysis of the blood-brain barrier in zebrafish. Brain Res. Bull. 2008, 75:619-628.
21. Jessberger S., Nakashima K., Clemenson G.D., Mejia E., Mathews E., Ure K., Ogawa S., Sinton C.M., Gage F.H., Hsieh J. Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J. Neurosci. 2007, 27:5967-5975.
22. Kim Y.J., Nam R.H., Yoo Y.M., Lee C.J. Identification and functional evidence of GABAergic neurons in parts of the brain of adult zebrafish (Danio rerio). Neurosci. Lett. 2004, 355:29-32.
23. Kim Y., Lee Y., Lee H., Jung M., Lee C. Impaired avoidance learning and increased hsp70 mRNA expression in pentylenetetrazol-treated zebrafish. Anim. Cells Syst. 2009, 13:275-281.
24. Lanneau D., Brunet M., Frisan E., Solary E., Fontenay M., Garrido C. Heat shock proteins: essential proteins for apoptosis regulation. J. Cell. Mol. Med. 2008, 12:743-761.
25. Loscher W. Basic pharmacology of valproate: a review after 35years of clinical use for the treatment of epilepsy. CNS Drugs 2002, 16:669-694.
26. McLean M.J., Macdonald R.L. Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 1986, 237:1001-1011.
27. Mortazavi F., Ericson M., Story D., Hulce V.D., Dunbar G.L. Spatial learning deficits and emotional impairments in pentylenetetrazole-kindled rats. Epilepsy Behav. 2005, 7:629-638.
28. Müller C.J., Bankstahl M., Gröticke I., Löscher W. Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage. Eur. J. Pharmacol. 2009, 619:15-24.
29. Ninkovic J., Bally-Cuif L. The zebrafish as a model system for assessing the reinforcing properties of drugs of abuse. Methods 2006, 39:262-274.
30. Pan T., Li X., Xie W., Jankovic J., Le W. Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. FEBS Lett. 2005, 579:6716-6720.
31. Picker M., White W., Poling A. Effects of phenobarbital, clonazepam, valproic acid, ethosuximide, and phenytoin on the delayed matching-to-sample performance of pigeons. Psychopharmacology (Berl) 1985, 86:494-498.
32. Piredda S., Yonekawa W., Whittingham T.S., Kupferberg H.J. Effects of antiepileptic drugs on pentylenetetrazole-induced epileptiform activity in the in vitro hippocampus. Epilepsia 1986, 27:341-346.
33. Rajesh K.R., Surendra R., Thangam J. Effect of valproic acid and carbamazepine on learning and memory in rats. Indian J. Pharmacol. 1991, 23:185-188.
34. Reif A., Hamelbeck B., Pfuhlmann B. Acute akinetic crisis with marked cognitive impairment due to Valproate treatment. Int. J. Geriatr. Psychiatry 2003, 18:356-357.
35. Ren M., Leng Y., Jeong M., Leeds P.R., Chuang D.M. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J. Neurochem. 2004, 89:1358-1367.
36. Sgobio C., Ghiglieri V., Costa C., Bagetta V., Siliquini S., Barone I., Di Filippo M., Gardoni F., Gundelfinger E.D., Di Luca M., Picconi B., Calabresi P. Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. Biol. Psychiatry 2010, 67:567-574.
37. Sirén A., Kylliäinen A., Tenhunen M., Hirvonen K., Riita T., Koivikko M. Beneficial effects of antiepileptic medication on absence seizures and cognitive functioning in children. Epilepsy Behav. 2007, 11:85-91.
38. Straussberg R., Kivity S., Weitz R., Harel L., Gadoth N. Reversible cortical atrophy and cognitive decline induced by valproic acid. Eur. J. Paediatr. Neurol. 1998, 2:213-218.
39. Umka J., Mustafa S., ElBeltagy M., Thorpe A., Latif L., Bennett G., Wigmore P.M. Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 2010, 166:15-22.
40. Winter M.J., Redfern W.S., Hayfield A.J., Owen S.F., Valentin J.P., Hutchinson T.H. Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J. Pharmacol. Toxicol. Meth. 2008, 57:176-187.